Last Price$59.76.8%
Market Cap$3,532.4M
259.8%
Industry median - (169.7%)
5Y Historical average - (1,202.0%)
248.4%
Industry median - (172.9%)
5Y Historical average - (1,211.6%)
45.6%
Industry median - (41.2%)
5Y Historical average - (15.9%)
39.6%
Industry median - (39.5%)
5Y Historical average - (28.5%)
PTGX Capital Allocation Rating
PTGX Capital Allocation rating
6.7
PTGX Capital Allocation rating performance
PTGX Capital Allocation metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with PTGX Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$3,532.4M | 6.7 | 259.8% | 248.4% | 191.0% | 45.6% | 39.6% | 2.3% | 0.0% | |
$124.8B | 4.8 | (15.0%) | (22.6%) | (11.5%) | (3.3%) | (5.5%) | 0.1% | 1.3% | |
$77.0B | 6.0 | 25.7% | 18.1% | 25.3% | 13.7% | 10.3% | 1.4% | 4.1% | |
$34.4B | 4.2 | (41.3%) | N/A | (24.0%) | (4.8%) | (8.5%) | 2.2% | 0.0% | |
$30.7B | 3.9 | (7.2%) | (14.8%) | (4.0%) | (559.4%) | (2.6%) | 2.4% | 0.0% | |
$24.0B | 4.7 | (37.8%) | (45.6%) | (6.7%) | (3.5%) | (6.5%) | 0.8% | 0.0% | |
$14.5B | 5.5 | 14.5% | 9.6% | 37.0% | 12.9% | 6.4% | (2.8%) | 3.6% | |
$13.8B | 7.3 | 65.4% | 57.7% | 68.4% | 19.1% | 16.0% | (5.1%) | 7.3% | |
$13.4B | 6.2 | 11.0% | 3.5% | 15.1% | 7.7% | 5.5% | 1.0% | 0.5% | |
$13.3B | 4.5 | (3,335.4%) | (3,343.2%) | (2,216.2%) | (53.5%) | (51.1%) | 3.6% | 0.0% | |
$1,846.9M | 4.3 | (43.2%) | (47.6%) | (43.3%) | (25.3%) | (27.4%) | 1.2% | 0.0% |
FAQ
What is the Protagonist Therapeutics, Inc. (PTGX) ROIC (Return on Invested Capital)?
The Protagonist Therapeutics, Inc. (PTGX) ROIC is 259.8%, compared to the industry median of ((169.7%)) and the 5-year historical average of (1,202.0%).
What is the Protagonist Therapeutics, Inc. (PTGX) ROIC minus WACC (Weighted Average Cost of Capital)?
The Protagonist Therapeutics, Inc. (PTGX) ROIC minus WACC is 248.4%, compared to the industry median of ((172.9%)) and the 5-year historical average of (1,211.6%).
What is the Protagonist Therapeutics, Inc. (PTGX) ROE (Return on Equity)?
The Protagonist Therapeutics, Inc. (PTGX) ROE is 45.6%, compared to the industry median of ((41.2%)) and the 5-year historical average of (15.9%).
What is the Protagonist Therapeutics, Inc. (PTGX) ROCE (Return on Capital Employed)?
The Protagonist Therapeutics, Inc. (PTGX) ROCE is 39.6%, compared to the industry median of ((39.5%)) and the 5-year historical average of (28.5%).